Merck, Roche in cancer diagnostics deal

Merck & Co. Inc. (NYSE:MRK) and Roche (SIX:ROG; OTCQX:RHHBY) partnered to

Read the full 114 word article

How to gain access

Continue reading with a
two-week free trial.